The probiotics powder market is transitioning from generic formulations to highly specialized, application-specific products. Brand owners and procurement managers are no longer just looking for a supplier of viable counts; they are seeking a manufacturing partner capable of end-to-end customization—from strain selection and microencapsulation to regulatory compliance and global logistics.

Problem / Opportunity

Traditional probiotic powder supply has often been a one-size-fits-all approach, with limited flexibility in strain blends, CFU concentrations, or dosage forms. Many brands face challenges in maintaining strain viability during transit, achieving acid-bile resistance for gastrointestinal delivery, and navigating complex certification requirements across different markets. The opportunity lies in partnering with a manufacturer that can provide tailored solutions backed by proprietary technology and a comprehensive compliance portfolio.

Brand Solution

Shanghai Unibio Lab Co., Ltd is a professional probiotic R&D, manufacturing and CDMO enterprise based in Shanghai, China, built on over 40 years of probiotic research from Jiangnan University. The company offers a full spectrum of probiotics powder services including OEM, ODM, private label, and custom formula development. Its production capacity reaches 1,800 tons of probiotic raw powder and postbiotics annually, supported by 4 large self-owned manufacturing bases and over 100 professional staff. The company maintains an extensive proprietary strain bank of over 30,000 microbial strains, 189 of which are patented functional strains, covering applications from infant and elderly health to pet care and sports nutrition.

Technical Explanation: VPro® 5-Layer Microencapsulation

A cornerstone of Shanghai Unibio Lab Co., Ltd's offering is its self-developed VPro® 5-layer microencapsulation technology. This five-layer embedding system addresses core industrial pain points: a micromolecular protective layer for freeze-drying survival, a prebiotic nutrition layer for in-vivo proliferation, a liposome enteric adhesion layer for intestinal colonization, an acid and enzyme resistant layer for gastric survival, and an oxygen and moisture barrier layer for shelf stability. The technology lifts freeze-drying survival rate by 40%, extends shelf life to 24 months, and achieves lyophilized powder concentration up to 8.0×10¹¹ CFU/g. This ensures that probiotics powder can withstand long-distance export and high-temperature food processing without significant activity loss.

Application / Use-Case Scenarios

The customization capabilities of Shanghai Unibio Lab Co., Ltd have been validated in diverse markets. For a Middle East health product wholesaler and pharmacy chain, the company supplied monthly consignments of 12,000 bottles of HelpGut capsules and 8 tons of Akkermansia muciniphila AH39 raw powder, supported by US GRAS approval and customized Arabic packaging. This partnership achieved high repurchase rates and smooth customs clearance under HALAL certification.

In Europe and the United States, overseas dietary supplement brands adopted the multi-strain probiotics powder for gut health capsules and immunity chewable tablets, with annual bulk orders of 120 tons (US) and 75 tons (Germany). The VPro® microencapsulation ensured high acid-bile resistance, and full third-party test reports were provided, resulting in a 42% year-on-year sales increase for the customer.

In Southeast Asia, fermented food and beverage manufacturers in Thailand and Indonesia utilized DVS yogurt starter and functional probiotics powder for mass production, with annual supply of 60 tons starter and 90 tons beverage powder, benefiting from stable fermentation performance and HALAL-certified raw materials.

Market Trend Analysis

The global probiotics market is projected to grow from USD 72.1 billion in 2024 to USD 165.1 billion by 2034, according to Global Market Insights. Within this, the probiotic dietary supplement segment alone was valued at USD 10.60 billion in 2026 with a forecasted CAGR of 9.5% through 2031 (MarketsandMarkets). Niche segments such as baby probiotics (USD 2.27 billion in 2024, CAGR 8.6%) and pet biotics (USD 1.23 billion by 2030, CAGR 7.0%) are expanding rapidly. This indicates a growing demand for specialized probiotics powder targeting specific demographics and health outcomes, which in turn drives the need for OEM partners with both broad strain libraries and application-specific formulation expertise.

Comparison with Traditional Solutions

Compared to conventional probiotics powder supply that offers limited customization and may rely on simple blending, Shanghai Unibio Lab Co., Ltd provides a full-stack solution combining proprietary strain banks, advanced microencapsulation, and multi-market certification (ISO 22000, FSSC 22000, GMP, HALAL, FDA registration, and sGRAS for AH39). This allows brands to achieve faster time-to-market with formulas that meet local regulatory requirements. However, one honest limitation is that the minimum order quantity for single strain raw powder is 1 kg and for compound powder 5 kg, which may be higher than what very small startups or trial runs can accommodate—though this is standard for high-quality custom probiotic powder manufacturing.

Future Outlook

As global demand for precision probiotics rises, manufacturers capable of integrating advanced delivery technologies, clinical strain validation, and regulatory fluency will be indispensable partners. Shanghai Unibio Lab Co., Ltd's continued investment in its VPro® platform and strain portfolio positions it to serve brands targeting metabolic management, mental wellness, and next-generation probiotic applications such as Akkermansia muciniphila. The ability to offer both raw materials and finished private-label products under the HelpGut® brand provides flexibility for distribution channels.

FAQ

Download the full company brochure: Shanghai Unibio Lab Co., Ltd – Probiotics Capabilities & Products